|Articles|May 1, 2019
- Pharmaceutical Executive-05-01-2019
- Volume 39
- Issue 5
Pharmaceutical Executive, May 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Impact Investing and R&Dabout 7 years ago
New Flare-Up in Europe's External Reference Pricing Debateabout 7 years ago
It’s Time for a Chief Adherence Officerabout 7 years ago
Adopting New Technology: Barriers and Breakthroughsabout 7 years ago
The CFO Evolutionabout 7 years ago
We’ve Got You Coveredabout 7 years ago
Survey Spotlights the CFO’s Strategic Riseabout 7 years ago
FDA After Gottlieb: Thorny Issues, Political Challengesabout 7 years ago
Easing the Path to Profitabilityabout 7 years ago
A Strategic Approach to Pharma R&D Portfolio PlanningAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The New Healthy Aging Imperative and What It Means for Pharma
2
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
3
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
4
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
5